Tags: Drug.

Iloprost is a drug used to treat pulmonary arterial hypertension (PAH) scleroderma Raynaud’s phenomenon and ischemia. It was developed by the pharmaceutical company Schering AG and is marketed by Bayer Schering Pharma AG in Europe and Actelion Pharmaceuticals in the USA.

Iloprost_2D_structure.svg
ATC prefix
B01
ATC suffix
AC11
CAS number
78919-13-8
DrugBank
DB01088
FDA UNII code
JED5K35YGL
IUPAC name
5-(E)-(1S5S6R7R)-7-hydroxy-6[(E)-(3S4RS)-3-hydroxy-4-methyl-1-octen-6-inyl]-bicyclo[3.3.0]octan-3-ylidenepentanoic acid
PubChem
6435378

Loading...

This page contains content from the copyrighted Wikipedia article "Iloprost"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.